Radiation Guidelines Issued for Bladder Cancer Treatment
New standards help patients understand the role of radiation therapy in managing muscle-invasive bladder cancer.
Updated on Sept. 18, 2026 in Cancer
Live Poll
Do you trust clinical guidelines to improve health outcomes for patients with cancer?
The American Society for Radiation Oncology has released updated clinical practice guidelines for using radiation therapy to treat muscle-invasive bladder cancer. These recommendations offer a framework for patients and their care teams to evaluate bladder-sparing treatments and post-surgical options.
Why it matters
These guidelines clarify when radiation therapy can improve local cancer control after surgery and offer strategies for symptom relief. By standardizing these practices, the recommendations help ensure patients receive consistent, evidence-based care for both curative and palliative needs.
The clinical practice guidelines were developed through an evidence-based analysis of radiation therapy indications across various bladder cancer settings. The recommendations address clinical management for muscle-invasive disease and post-surgical care, though comparative survival outcomes remain an area of ongoing study.
The players
American Society for Radiation Oncology
A professional organization that establishes clinical standards for the use of radiation therapy in cancer treatment.
The details
The guidelines advocate for the use of intensity-modulated radiation therapy, which employs daily image guidance to precisely target tumors while sparing healthy surrounding tissue. For patients with muscle-invasive bladder cancer, trimodal therapy is presented as a bladder-sparing alternative to radical surgery. The protocol emphasizes combining radiation with systemic therapy to sensitize tumors and, in specific cases, using a partial tumor boost to optimize the radiation dose.
Timeline
Sept. 15, 2026: The American Society for Radiation Oncology published the guidelines in Practical Radiation Oncology.
Health Landscape
These guidelines refine the standard of care by integrating radiation therapy into the treatment pathway for specific stages of muscle-invasive bladder cancer. This represents a significant step in the historical arc of cancer care, balancing the necessity of local control with the goal of bladder preservation.
If you or a loved one are facing a muscle-invasive bladder cancer diagnosis, these guidelines may be useful for framing a conversation with your oncologist about bladder-sparing options. Discuss with your physician whether intensity-modulated radiation or adjuvant therapy is appropriate based on your specific tumor characteristics.
The takeaway
Radiation therapy is increasingly recognized as a key component of bladder-sparing treatment for select patients with muscle-invasive disease. Patients should consult their care team about whether these evidence-based protocols, such as trimodal therapy or post-surgical radiation, apply to their treatment plan.
Further reading
For more on evolving treatment standards, explore the Cancer section.
Live Poll
Do you trust clinical guidelines to improve health outcomes for patients with cancer?
